large DNA payload
Natural Nanocarriers
for Delivery of Genetic Medicine
We develop exosome-based delivery technology to bring powerful gene therapies to patients with life-threatening and currently incurable diseases.
About us
ExoVectory is a biotechnology company developing exosomes as a next-generation delivery platform for precision gene therapy. At the core of the company is a proprietary method for loading large therapeutic DNA sequences into exosomes with exceptional efficiency, enabling treatments to travel throughout the body, cross the blood-brain barrier, and reach target cells without toxic side effects. Our mission is to transform exosomes into precision delivery vehicles for next-generation genetic therapies targeting untreatable diseases.
MEET EXOVECTORY
Our Technology
At the heart of ExoVectory’s platform is ExoVec™ — a proprietary exosome loading and targeting technology. Using our unique Exosome Loading Proteins (ELPs), ExoVec™ packages therapeutic DNA of up to 36,000 base pairs, outperforming well-known gene therapy vectors, and enabling delivery of a wide range of payloads, from CRISPR-Cas editing tools to cancer-killing viral genomes. Our loaded exosomes offer two further advantages: they penetrate deep into tumour masses and remain invisible to the immune system, avoiding the antibody responses that limit other delivery systems. Combined with surface-level targeting proteins, this makes our platform uniquely precise, powerful and scalable towards the clinic.
large DNA payload
minimal toxicity
superior delivery
company evolution
- Company foundation
- Procured Investment
- Prototype development
- IP granting
- Grants and collaborations
- Lead programs identification
- Production process fine-tuning
- Pre-clinical validation
- Industry partnerships
- Clinical PoC
- Product diversification
- Platform out-licensing
- Revenue expansion
Pipeline
ExoVectory is advancing ExoVec™ through various therapeutic programmes, with an emphasis on genetic diseases and cancers where existing treatments fall short.
Ready to deliver your cargo
further than ever before?
ExoVectory combines world-class expertise in exosome biology, proprietary loading and targeting technology, and a growing track record of academic and industry collaborations. Whether you are looking to explore ExoVec™ as a delivery solution, co-develop a therapeutic programme, or access our exosome platform for your own research, we are open to partnerships that bring new treatments closer to patients.
CONTACT US